Alemtuzumab treatment of multiple sclerosis in real-world clinical practice: a report from a single Italian center.
ConclusionsIn a real-world MS population like the one investigated in our study, alemtuzumab was found to be an effective treatment when employed as an escalation or rescue therapy. The compound exhibits a variable safety profile and frequent adverse events that are likely depending on previous treatments and their impact on the immune system.
Source: Multiple Sclerosis and Related Disorders - Category: Neurology Source Type: research
More News: Anemia | Autoimmune Disease | Disability | Hepatitis | Italy Health | Men | Multiple Sclerosis | Neurology | Pancytopenia | Study